Client’s Testimonial:
“Thank you very much for all the help.”
On March 22nd, 2022, we received another EB-1A (Alien of Extraordinary Ability) approval for a Research Scientist in the Field of Machine Learning (Approval Notice).
General Field: Machine Learning
Position at the Time of Case Filing: Research Scientist
Country of Origin: Italy
State of Residence at the Time of Filing: New York
Approval Notice Date: March 22nd, 2022
Processing Time: 1 month, 8 days (Premium Processing Requested)
Case Summary:
“By developing programs that offer a more in-depth understanding of gene and protein characteristics, [the client] has produced a method for advancing the efficiency of drug discovery processes in the United States. The United States possesses the largest pharmaceutical market in the world, and the nation is also a leader in drug discovery. Considering that more than 20 percent of most pharmaceutical companies’ income annually is dedicated to research, it is vital to optimizing the drug discovery process in order to efficiently deliver needed and safe drugs to the market for public consumption.”
Issued in favor of one of our clients by an expert in Machine Learning, the above statement is one of the many testimonials we gathered during our case preparation for a research scientist from Italy. Our client was one of the few leading experts focused on analyzing complex and large datasets. He is especially well-known for his work on designing graph neural networks (GNNs) that adapt to complex and changing real-world datasets.
The field had already recognized his authority by inviting him to review and evaluate the work of his peers no fewer than 14 times. He has also actively engaged his peers in the field of machine learning by authoring and co-authoring 22 peer-reviewed articles and 8 book chapters that have been published in international journals and conference proceedings. Additionally, his overall work related to the improvement of Machine Learning applications has been cited 712 times by researchers in at least 48 countries by peers using his prior findings to make additional discoveries related to topics like genetic annotation, motion detection, and graphing real-world data. He is in the top 1% of most highly cited authors publishing on topics in computer science over the past 10 years according to Essential Science Indicator statistics.
Thus, we identified that he is one of the few leading experts focused on Machine Learning for analyzing complex and large datasets, and he has achieved a consistent and notable record of success and influence in this field of study. This led our team to build a specialized letter of petition for him using all of the above information and more, collected from his academic and professional documents. We knew that the USCIS expects the EB1-A (Alien of Extraordinary Ability) applicants to give clear proof of their extraordinary ability in the relevant field. So, we moved accordingly to prepare his case, winning him approval in just 36 days.
We thank our client for his trust in our firm and we wish him all the best in every future endeavor. We look forward to further collaboration with him in the future.
North America Immigration Law Group (Chen Immigration Law Associates) is a U.S. immigration law firm dedicated to representing corporations, research institutions, and individuals from all 50 U.S. states regarding I-140 immigration petitions. We specialize in employment-based immigration petition and have a proven record of high success rate for the categories of: EB2-NIW (National Interest Waiver), EB1-A (Alien of Extraordinary Ability), EB1-B (Outstanding Researcher/Professor) and O-1 (Alien of Extraordinary Ability).
Our Ten Thousand I-140 Approvals Provide Unprecedented Insight into the USCIS Adjudication Trend
With more than 47,000 EB-1A, EB-1B, EB-2 NIW and O-1 cases approved, we have first hand information on the manner in which the USCIS adjudicate I-140 cases. As the USCIS has constantly changed its adjudication standards for the EB-1A, EB-1B and EB-2 NIW categories, our firm's huge database of successful cases gives you unprecedented insight to USCIS adjudication trends. We carefully analyze the data for all of our cases and apply the results of our analyses toward giving our clients up-to-date advice and adapting our strategies such that we remain on par with the ever-shifting landscape of immigration law in the U.S. With us, you will always have access to important updates, strategies, and information so that you can make the most informed decisions about your case.
We Have Helped Hundreds and Thousands of Clients with Credentials and Backgrounds Similar to Yours
With our exceedingly large number of successful petitions, no matter what credentials you have, no matter your background and field of expertise, no matter your visa status or nationality, chances are we have helped hundreds or even thousands of clients just like you. Our clients are usually impressed with how well we understand their research and work. Our insight and understanding stems from the fact that we have handled many cases with elements similar to yours already, and this helps us devise the best strategies for each individual petition.
Vast Majority of Clients Came to Us Because of Referrals
For years, our firm has attracted new clients based solely on word of mouth, recommendations, and the positive collaboration experiences shared with them by their friends and family. We take pride in our reputation and work hard to ensure that we provide a green card application experience that our clients are happy to share with their friends and colleagues. That is how our approved cases grew from 600 in 2013 to over 47,000 in 2023.
Approval Notices: https://www.wegreened.com/eb1_niw_approvals
Success Stories: https://www.wegreened.com/blog/
Website: www.wegreened.com
Free evaluation: https://www.wegreened.com/Free-Evaluation
Tel: 888.666.0969 (Toll Free)
To see more clients’ testimonials and approvals, please refer to:
To Learn More About Your Options CLICK HERE
Copyright © North America Immigration Law Group – WeGreened.com, All Rights Reserved.